Navigation Links
Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial

5-9905

Investors: Amy Sullivan (617) 995-9838

CONTACT: Media, Teri Dahlman +1-617-995-9905, or Investors, Amy Sullivan,+1-617-995-9838, both of Idenix Pharmaceuticals, Inc.

Web site: http://www.idenix.com/http://www.cdc.gov/ncidod/diseases/hepatitis/c/fact.htm/

Ticker Symbol: (NASDAQ-NMS:IDIX)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Idenix Reports Results from Two Phase IIb Studies of the Combination of Valopicitabine and Pegylated Interferon in Hepatitis C Genotype-1 Patients at the 42nd Annual Meeting of the European Association for the Study of the Liver
2. New Data Show Pfizers Axitinib Prolonged Overall Survival in Advanced Pancreatic Cancer When Combined with Standard of Care Chemotherapy
3. Investigational Cancer Drug Pertuzumab Shows Promising Results in Advanced Breast Cancer When Combined with Herceptin
4. Low-Dose Steroid Combined With Lenalidomide Prolongs Survival Compared With High-Dose Steroid for Multiple Myeloma Treatment
5. RTA 402 Shown to Protect Animals Against Toxicities of Standard Cancer Treatments
6. Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid Arthritis Compared to a Current Standard of Care
7. Repros Reports That Proellex Has Demonstrated Superior Efficacy and Safety in Endometriosis When Compared to Standard of Drug Care
8. Interim Data From RECORD Study Show No Significant Difference Between Avandia and Standard Therapy in Risk of Cardiovascular Hospitalization or Death
9. Clinical Trial Results Change Standard of Care for Pancreatic Cancer Patients, Future Therapies Discussed
10. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
11. Phase 2 Clinical Results of Ganite Plus Standard Therapy in Patients with Relapsed/Refractory Lymphoma Presented at ASCO
Post Your Comments:
(Date:6/3/2015)... Md. , June 3, 2015  GenVec, Inc. ... with Dr. David T. Curiel and his ... at St. Louis (WUSTL).  Dr. ... and the Cancer Biology Division within the Department of ... and the WUSTL team will create modified versions of ...
(Date:6/3/2015)... MENLO PARK, Calif. , June 3, 2015 ... novel small molecule drugs for cardiovascular diseases, today ... MPH, has been appointed Chief Executive Officer, effective ... of experience in global, high-growth enterprises, with a ... the improvement of human health. With expertise that ...
(Date:6/3/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/6xfc66/europe_ct_market ) ... Market - Growth, Trends And Forecasts (2014 - 2019)" ... (CT) is an imaging process that customs special x-ray ... scans, of areas inside the body. It is also ... It is primarily used in the Cancer diagnosis process. ...
Breaking Medicine Technology:GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines 2GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines 3GenVec And Washington University at St. Louis Form Collaboration To Discover Targeted Adenovector-Based Therapeutics And Vaccines 4Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 2Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 3Armetheon Names Dr. Sanjay Kakkar as Chief Executive Officer 4Europe CT Market Report 2015-2019 - Growth, Trends And Forecasts 2
(Date:6/3/2015)... Justina Molzon, MS Pharm, JD will be honored ... Meeting. DIA’s Global Inspire Award program recognizes the organization’s ... commitment to service on a global scale. ... that recognizes the “Member of the Year” who consistently ... has contributed to the advancement of DIA’s mission. ...
(Date:6/3/2015)... 03, 2015 Researchers at the University ... mesothelioma and say the tried-and-true marker mesothelin is the ... article on the research. Click here to read ... Center for Asbestos Related Diseases say, even though a ... is still preferable to fibulin-3 for identifying mesothelioma. ...
(Date:6/3/2015)... June 03, 2015 Acne is the same ... be particularly stubborn to eliminate and hard to prevent. As ... in teens and young adults, in the years when the ... or oil,” says Jayme Bashian, director and lead medical aesthetician ... blackheads and cysts of acne are caused by oil and ...
(Date:6/3/2015)... First Choice Emergency Room , the ... United States, announced that it is opening its new ... , “I am pleased to announce that we are ... in the San Antonio area,” said Dr. James M. ... , First Choice Emergency Room is revolutionizing the ...
(Date:6/3/2015)... 03, 2015 Come on out in ... a 200-mile overnight relay beginning in Madison, Wisconsin on ... Saturday, June 13th. , For the 4th consecutive year, ... will run to raise money for the Brain Aneurysm ... members of the Neurosurgery staff from The University of ...
Breaking Medicine News(10 mins):Health News:Former FDA Official and U.S. Public Health Service Officer to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 2Health News:Former FDA Official and U.S. Public Health Service Officer to Be Honored with Global Inspire Award at DIA’s 2015 51st Annual Meeting 3Health News:Analysis Reveals Gold Standard Mesothelioma Biomarker Still the Best, According to Surviving Mesothelioma 2Health News:Back Acne: Tips for Clearer Summer Skin 2Health News:Back Acne: Tips for Clearer Summer Skin 3Health News:First Choice Emergency Room to Open New Facility in San Antonio, Texas 2Health News:4th Annual Ragnar Relay from Madison, WI to Chicago, IL Once Again Benefits Renowned Brain Aneurysm Foundation 2
... Protecting ... seeing up-close this summer simple and stylish , ... Miami, FL (PRWEB) June 2, 2010 -- VisAcuity.com today ... , , ,“We’ve invested nearly 12 months to gather this year’s exclusive collection of ...
... (May 29, 2010) -- Physician-scientists from NewYork-Presbyterian Hospital/Weill ... findings at the American Urological Association,s Annual Meeting ... Dr. Steven Kaplan, a urologist and ... Center, and Dr. Darracott Vaughan, senior author and ...
... A minimally invasive technique used to destroy kidney ... effectiveness as surgical removal of tumors in curbing cancer ... In an article available online in the journal ... and radiology at UT Southwestern Medical Center, reported the ...
... The National Institutes of Health (NIH) has awarded ... University a five-year, $3.9 million grant to study how ... Africa. The findings could alter public health approaches for ... "Most cases of XDR-TB are thought to arise when ...
... ... demanding enterprise customers with VMware and Microsoft Hyper-V environments. , ... (PRWEB) June 2, 2010 -- VKernel, the ... announced today the general availability of VKernel Optimization Pack 1.4. The latest version ...
... and perhaps more aggressive ones, found in heaviest men, study ... among prostate cancer patients appears to be linked to patient ... reveals. , The finding stems from work involving more ... 60 who underwent surgery between 2001 and 2007 to remove ...
Cached Medicine News:Health News:Sun Reading Glasses Collection Debuts 2Health News:NewYork-Presbyterian/Weill Cornell physician-scientists present at 2010 American Urological Meeting 2Health News:NewYork-Presbyterian/Weill Cornell physician-scientists present at 2010 American Urological Meeting 3Health News:Ablation proved as effective as traditional surgery in treating kidney cancer 2Health News:Einstein awarded NIH grant to study drug-resistant TB 2Health News:Einstein awarded NIH grant to study drug-resistant TB 3Health News:VKernel Raises Scalability and Reporting Bar with Optimization Pack 1.4 2Health News:Size of Prostate Tumor Linked to Patients' Weight 2
The Urine Legionella Antigen ELISA kit detects the presence of Legionella pneumophila serogroup1 antigen in urine....
Measles IgG ELISA....
Toxoplasma IgM II ELISA....
Herpes Simplex Virus 2 IgG ELISA....
Medicine Products: